Telix Pharmaceuticals (TLX) Enterprise Value (2023 - 2025)
Telix Pharmaceuticals (TLX) posted Enterprise Value of -$141.9 million for Q4 2025, up 69.46% on a QoQ basis from -$464.5 million in Q4 2024, and up 69.46% year-over-year from -$83.7 million in Q4 2024.
Telix Pharmaceuticals (TLX) has 3 years of Enterprise Value data on file, last reported at -$141.9 million in Q4 2025.
- In Q4 2025, Enterprise Value rose 69.46% year-over-year to -$141.9 million; the TTM figure through Dec 2025 stood at -$141.9 million (up 69.46% YoY), while the FY2025 annual figure was -$141.9 million, up 69.46% from the prior year.
- Enterprise Value advanced to -$141.9 million in Q4 2025, from -$464.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$80.2 million in Q4 2023 and bottomed at -$464.5 million in Q4 2024.
- A 3-year average of -$228.9 million and a median of -$141.9 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value sank 479.03% — and 2025, when it surged 69.46%.
- Year by year, Enterprise Value stood at -$80.2 million in 2023, then sank by 479.03% to -$464.5 million in 2024, then surged by 69.46% to -$141.9 million in 2025.
- The last three Enterprise Value figures came in at -$141.9 million (Q4 2025), -$464.5 million (Q4 2024), and -$80.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Telix Pharmaceuticals | 4.52 Bn | 4.38 Bn | - | -141.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -141.87 Mn |
| Dec 31, 2024 | -464.54 Mn |
| Dec 31, 2023 | -80.23 Mn |